Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease being developed by Hoffmann-La Roche pharmaceuticals.
Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease being developed by Hoffmann-La Roche pharmaceuticals.
Gantenerumab binds to and clears aggregated beta amyloid fibers.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).